FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for SILIQ (brodalumab) filed by Bausch Health US LLC, updating the product's labeling to reflect the approved change…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SILIQ (brodalumab)

Snippet

SUPPL AP for SILIQ (BRODALUMAB)